| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/01/2005 | US6861256 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 03/01/2005 | US6861242 Reacting glucosidase and phosphotransferase |
| 03/01/2005 | US6861241 Human kinase and polynucleotides encoding the same |
| 03/01/2005 | US6861238 Retinoid metabolizing protein |
| 03/01/2005 | US6861236 Harvesting antibiotic peptides comprising transport protein leader sequences |
| 03/01/2005 | US6861228 Modulating Robo: ligand interactions |
| 03/01/2005 | US6861227 For diagnosing disorders related to the immune system; therapy and prophylaxis |
| 03/01/2005 | US6861064 Encapsulation method |
| 03/01/2005 | US6861059 Administering DP-107 or a pharmaceutically acceptable derivative thereof along with at least one therapeutic agent; synergistic |
| 03/01/2005 | US6861058 Relieving pain related to muscle activity or contracture, antispasmodic |
| 03/01/2005 | US6861057 Immunogenic β-amyloid peptide |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 03/01/2005 | US6861054 suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof |
| 03/01/2005 | US6860907 Method of particle formation |
| 03/01/2005 | CA2390110C Modular transport systems for molecular substances and production and use thereof |
| 03/01/2005 | CA2346257C Method for obtaining active .beta.-ngf |
| 03/01/2005 | CA2133326C Fusion proteins comprising tumor necrosis factor receptor |
| 02/28/2005 | CA2479474A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same, and uses thereof |
| 02/24/2005 | WO2005017526A1 Reconstitution medium for protein and peptide formulations |
| 02/24/2005 | WO2005017208A1 Compositions and methods for treating or preventing hiv infection |
| 02/24/2005 | WO2005017177A2 Modulators of nod1 signaling |
| 02/24/2005 | WO2005017163A2 Phenotypic knockout of cell-surface proteins |
| 02/24/2005 | WO2005017160A2 Mobilization of hematopoietic cells |
| 02/24/2005 | WO2005017151A1 End-deficient mutant of ip3 receptor protein inducing apoptosis |
| 02/24/2005 | WO2005017139A1 Thrombin from venom of agkistrodon acutus used as drugs for the treatment of haemorrhage |
| 02/24/2005 | WO2005017133A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | WO2005017127A2 Rna interference compositions and methods |
| 02/24/2005 | WO2005017097A2 Quorum sensing and biofilm formation |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016965A1 Modulators of the potassium channels twik-1, task-1, girk1, sk2 or pcn1, used to treat arrhythmia, coronary heart disease or hypertension |
| 02/24/2005 | WO2005016963A2 Heparin binding veger-3 ligands |
| 02/24/2005 | WO2005016960A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | WO2005016958A2 Compounds for treating tumors |
| 02/24/2005 | WO2005016953A2 Antagonistic analogs of gh-rh (2003) |
| 02/24/2005 | WO2005016947A2 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 02/24/2005 | WO2005016380A1 Methods of therapy for chronic lymphocytic leukemia |
| 02/24/2005 | WO2005016375A1 C1-inh as a drug for treating viruses pathogenic to humans |
| 02/24/2005 | WO2005016374A1 Regulation of urokinase receptor expression by phosphoglycerate kinase |
| 02/24/2005 | WO2005016373A1 Osteogenesis promoter |
| 02/24/2005 | WO2005016372A1 Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals |
| 02/24/2005 | WO2005016371A1 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES |
| 02/24/2005 | WO2005016370A1 Method of treating viral infections |
| 02/24/2005 | WO2005016369A1 Use of a vegf antagonist in combination with radiation therapy |
| 02/24/2005 | WO2005016368A2 Use of phosphophoryn for inducing biomineralization and bone regeneration |
| 02/24/2005 | WO2005016367A1 Therapeutic preparation for hematopoietic disease |
| 02/24/2005 | WO2005016366A2 Method to inhibit the propagation of an undesired cell population |
| 02/24/2005 | WO2005016365A2 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 02/24/2005 | WO2005016364A1 Skin care composition including hexapeptide complexes and methods of their manufacture |
| 02/24/2005 | WO2005016355A1 Intravascular delivery of non-viral nucleic acid |
| 02/24/2005 | WO2005016342A1 Sir2 regulation |
| 02/24/2005 | WO2005016340A1 Furanone derivatives |
| 02/24/2005 | WO2005016312A1 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
| 02/24/2005 | WO2005016297A1 Hair regenerator |
| 02/24/2005 | WO2005016288A2 Methods and compositions for treatment of viral diseases |
| 02/24/2005 | WO2005016285A2 Compositions and methods for inhibiting slit protein and glypican interactions |
| 02/24/2005 | WO2005016280A2 Orally administered small peptides synergize statin activity |
| 02/24/2005 | WO2005016275A2 Formulations containing an immune response modifier |
| 02/24/2005 | WO2005016273A2 Infection prophylaxis using immune response modifier compounds |
| 02/24/2005 | WO2005016266A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | WO2005016265A2 Method for promoting bone growth |
| 02/24/2005 | WO2005016257A2 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/24/2005 | WO2005016256A2 Hemostatic compositions containing sterile thrombin |
| 02/24/2005 | WO2005016254A2 Methods and reagents for treating inflammation and fibrosis |
| 02/24/2005 | WO2005016248A2 A novel antiproliferative factor and methods of use |
| 02/24/2005 | WO2005016247A2 Dna sequences, peptides, antibodies and vaccines for prevention and treatment of sars |
| 02/24/2005 | WO2005016244A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 02/24/2005 | WO2005016241A2 Synthetic chemokine receptor ligands and methods of use thereof |
| 02/24/2005 | WO2005016227A2 Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof |
| 02/24/2005 | WO2005016127A2 Prion-specific peptide reagents |
| 02/24/2005 | WO2005016126A2 Multifactorial assay for cancer detection |
| 02/24/2005 | WO2005009338A3 Method of inhibiting atf/creb and cancer cell growth and pharmaceutical compositions for same |
| 02/24/2005 | WO2005007183A3 Treatment of anemia |
| 02/24/2005 | WO2005002494A3 Pharmaceutical active ingredient to combat prostatic cancer |
| 02/24/2005 | WO2005000872A3 Collagen mimics |
| 02/24/2005 | WO2004113375A3 Antimicrobial compositions and uses thereof |
| 02/24/2005 | WO2004113363A3 Dipeptide transglutaminase inhibitors and methods of using the same |
| 02/24/2005 | WO2004112697A3 Immune enhancing composition containing lactoferrin |
| 02/24/2005 | WO2004111218A3 Method for producing glucoamylases and their uses |
| 02/24/2005 | WO2004104031A3 Modified antiviral peptides with increased activity and cell membrane affinity |
| 02/24/2005 | WO2004091436A3 Methods and compositions for treating ocular disease |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004087194A3 Use of a dg931 protein for treating diabetes, obesity and metabolic syndrome |
| 02/24/2005 | WO2004085664A3 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |
| 02/24/2005 | WO2004077062B1 Method for selecting a candidate drug compound |
| 02/24/2005 | WO2004072099A3 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 02/24/2005 | WO2004056865A3 Method of modulation of interaction between receptor and ligand |
| 02/24/2005 | WO2004056386A3 Nucleic acids involved in blood-brain barrier control |
| 02/24/2005 | WO2004031409A3 Method for diagnosing chronic myeloid leukemia |
| 02/24/2005 | WO2004030636A3 Human papillomavirus polypeptides and immunogenic compositions |
| 02/24/2005 | WO2004027041A3 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2003106650A3 Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 02/24/2005 | WO2003102206A3 Sgk and nedd used as diagnostic and therapeutic targets |
| 02/24/2005 | WO2003099851A3 Methods and compositions for inhibiting hiv replication |
| 02/24/2005 | WO2003093503A3 Method for bioequivalence determination using expression profiling |
| 02/24/2005 | WO2003093299A3 Insulin-associated peptides with effects on cerebral health |
| 02/24/2005 | WO2003068160A3 Use of insulin-like growth factor binding protein 3 (igf-bp3) for inhibition of tumor growth |
| 02/24/2005 | WO2003064616A3 Compounds and methods for inducing growth arrest and apoptosis |
| 02/24/2005 | WO2003061362A3 Methods and compositions for treating polycystic ovary syndrome |
| 02/24/2005 | WO2003059273A3 Antibody-avidin fusion proteins as cytotoxic drugs |